IL141660A0 - Sequences characteristic of hypoxia-regulated gene transcription - Google Patents

Sequences characteristic of hypoxia-regulated gene transcription

Info

Publication number
IL141660A0
IL141660A0 IL14166099A IL14166099A IL141660A0 IL 141660 A0 IL141660 A0 IL 141660A0 IL 14166099 A IL14166099 A IL 14166099A IL 14166099 A IL14166099 A IL 14166099A IL 141660 A0 IL141660 A0 IL 141660A0
Authority
IL
Israel
Prior art keywords
hypoxia
gene transcription
regulated gene
sequences characteristic
sequences
Prior art date
Application number
IL14166099A
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of IL141660A0 publication Critical patent/IL141660A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14166099A 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription IL141660A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9815898P 1998-08-27 1998-08-27
US13268499P 1999-05-05 1999-05-05
PCT/US1999/020394 WO2000012525A1 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription

Publications (1)

Publication Number Publication Date
IL141660A0 true IL141660A0 (en) 2002-03-10

Family

ID=26794273

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14166699A IL141666A0 (en) 1998-08-27 1999-08-27 Hypoxia regulated genes
IL14166099A IL141660A0 (en) 1998-08-27 1999-08-27 Sequences characteristic of hypoxia-regulated gene transcription

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL14166699A IL141666A0 (en) 1998-08-27 1999-08-27 Hypoxia regulated genes

Country Status (6)

Country Link
EP (2) EP1107797A4 (en)
JP (2) JP2002525081A (en)
AU (1) AU5810999A (en)
CA (2) CA2341705A1 (en)
IL (2) IL141666A0 (en)
WO (2) WO2000012139A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． Electric muscle control device
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
NZ526617A (en) * 2000-11-28 2004-09-24 Wyeth Corp Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60237406D1 (en) * 2001-05-31 2010-09-30 Chiba Prefecture Nucleic acids isolated from a neuroblastoma
WO2003000012A2 (en) 2001-06-21 2003-01-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2004041170A2 (en) * 2002-11-01 2004-05-21 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
JP2007517498A (en) * 2003-10-07 2007-07-05 アステラス製薬株式会社 Bone morphogenic protein (BMP) 2A and uses thereof
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
CA2594673A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
JP2011206049A (en) * 2010-03-08 2011-10-20 Sumio Sugano Necrosis marker and use thereof
JP2013220090A (en) * 2012-04-19 2013-10-28 Tohoku Univ Drug screening method for use in eye disease treatment
CN110177544A (en) 2016-11-29 2019-08-27 普尔泰克健康有限公司 For delivering the excretion body of therapeutic agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000353A1 (en) 1991-06-20 1993-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product
US5731294A (en) * 1993-07-27 1998-03-24 Hybridon, Inc. Inhibition of neovasularization using VEGF-specific oligonucleotides
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP1002862A1 (en) * 1998-11-12 2000-05-24 Nitsch, Roger M., Prof. Dr. Methods of diagnosing or treating neurological diseases

Also Published As

Publication number Publication date
WO2000012525A1 (en) 2000-03-09
JP2002525081A (en) 2002-08-13
EP1115733A1 (en) 2001-07-18
AU5810999A (en) 2000-03-21
CA2341705A1 (en) 2000-03-09
CA2341518A1 (en) 2000-03-09
WO2000012139B1 (en) 2000-05-04
WO2000012139A1 (en) 2000-03-09
JP2002523072A (en) 2002-07-30
EP1107797A4 (en) 2002-10-16
EP1115733A4 (en) 2003-01-22
EP1107797A2 (en) 2001-06-20
IL141666A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
IL141660A0 (en) Sequences characteristic of hypoxia-regulated gene transcription
HUP0103571A3 (en) Characterisation of gene function using double stranded rna inhibition
IL190391A0 (en) Genes for the biosynthesis of epothilones
HUP0003651A3 (en) Novel nucleotide sequences coding for the pgi gene
AU1824101A (en) Nucleotide sequences of moraxella catarrhalis genome
HK1043280A1 (en) Purified and isolated piwi family genes and gene products and methods employing same
AU1488501A (en) Methods of inhibiting metastasis
AU5910899A (en) Inhibition of oncogene transcription by synthetic polyamides
AUPQ659800A0 (en) Genetic sequences and uses therefor
EP1581614A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
AU5328600A (en) Nucleotide sequences for gene regulation and methods of use thereof
EP1066309A4 (en) Libraries of expressible gene sequences
AU1082701A (en) Short segments of dap-kinase
AUPP727398A0 (en) Methods of identifying antigen gene sequences
AU3807299A (en) Methods for quantitating low level modifications of nucleotide sequences
AU2001293741A1 (en) Nucleotide sequences coding for the suga gene
AU1381600A (en) Identification of senv genotypes
EP1095137A4 (en) Novel promoter sequences of myostatin gene
AU2001264845A1 (en) Nucleotide sequences encoding ramosa 1 gene and methods of use for same
AU2001289807A1 (en) Nucleotide sequences coding for the pstc2 gene
AU2001279804A1 (en) Nucleotide sequences coding for the hisc2 gene
AU2002224789A1 (en) Nucleotide sequences coding for the cysq gene
AU2001293730A1 (en) Nucleotide sequences which code for the chra gene
GB9814536D0 (en) Characterisation of gene function using double stranded rna inhibition
EP1066404A4 (en) Methods for producing libraries of expressible gene sequences